Uusküla A - Search Results

1

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.

Huik K, Avi R, Pauskar M, Kallas E, Jõgeda EL, Karki T, Rüütel K, Talu A, Abel-Ollo K, Uusküla A, Carrillo A, Ahuja SK, He W, Lutsar I. Huik K, et al. Among authors: uuskula a. PLoS One. 2016 Jun 15;11(6):e0156850. doi: 10.1371/journal.pone.0156850. eCollection 2016. PLoS One. 2016. PMID: 27304910 Free PMC article.

2

The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.

Mercadé-Besora N, Li X, Kolde R, Trinh NT, Sanchez-Santos MT, Man WY, Roel E, Reyes C, Delmestri A, Nordeng HME, Uusküla A, Duarte-Salles T, Prats C, Prieto-Alhambra D, Jödicke AM, Català M. Mercadé-Besora N, et al. Among authors: uuskula a. Heart. 2024 Apr 15;110(9):635-643. doi: 10.1136/heartjnl-2023-323483. Heart. 2024. PMID: 38471729 Free PMC article.

3

HIV epidemic in Estonia in the third decade of the AIDS era.

Rüütel K, Uusküla A. Rüütel K, et al. Among authors: uuskula a. Scand J Infect Dis. 2006;38(3):181-6. doi: 10.1080/00365540500388743. Scand J Infect Dis. 2006. PMID: 16507499 Review.

4

High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.

Platt L, Bobrova N, Rhodes T, Uusküla A, Parry JV, Rüütel K, Talu A, Abel K, Rajaleid K, Judd A. Platt L, et al. Among authors: uuskula a. AIDS. 2006 Oct 24;20(16):2120-3. doi: 10.1097/01.aids.0000247586.23696.20. AIDS. 2006. PMID: 17053361

5

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, Dehovitz J, Des Jarlais D. Uusküla A, et al. J Public Health (Oxf). 2008 Jun;30(2):119-25. doi: 10.1093/pubmed/fdn014. Epub 2008 Feb 28. J Public Health (Oxf). 2008. PMID: 18308743 Free PMC article.

6

Quality of life of people living with HIV and AIDS in Estonia.

Rüütel K, Uusküla A, Minossenko A, Loit HM. Rüütel K, et al. Among authors: uuskula a. Cent Eur J Public Health. 2008 Sep;16(3):111-5. doi: 10.21101/cejph.a3461. Cent Eur J Public Health. 2008. PMID: 18935773

7

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC. Vorobjov S, et al. Among authors: uuskula a. Harm Reduct J. 2009 Feb 20;6:3. doi: 10.1186/1477-7517-6-3. Harm Reduct J. 2009. PMID: 19232088 Free PMC article.

8

HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.

Talu A, Rajaleid K, Abel-Ollo K, Rüütel K, Rahu M, Rhodes T, Platt L, Bobrova N, Uusküla A. Talu A, et al. Among authors: uuskula a. Int J Drug Policy. 2010 Jan;21(1):56-63. doi: 10.1016/j.drugpo.2009.02.007. Epub 2009 Apr 22. Int J Drug Policy. 2010. PMID: 19395249

9

Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey.

Rüütel K, Pisarev H, Loit HM, Uusküla A. Rüütel K, et al. Among authors: uuskula a. J Int AIDS Soc. 2009 Jul 16;12:13. doi: 10.1186/1758-2652-12-13. J Int AIDS Soc. 2009. PMID: 19607721 Free PMC article.

10

Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD. Vorobjov S, et al. Among authors: uuskula a. J Urban Health. 2009 Nov;86(6):918-28. doi: 10.1007/s11524-009-9400-5. Epub 2009 Nov 18. J Urban Health. 2009. PMID: 19921542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters